Circulating hematopoietic stem and progenitor cells are myeloid-biased in cancer patients.
about
Neutrophils in the tumor microenvironment: trying to heal the wound that cannot heal.Tumor-induced myeloid dysfunction and its implications for cancer immunotherapyInvasive breast cancer reprograms early myeloid differentiation in the bone marrow to generate immunosuppressive neutrophils.Biology and flow cytometry of proangiogenic hematopoietic progenitors cells.Analysis of monocytic and granulocytic myeloid-derived suppressor cells subsets in patients with hepatitis C virus infection and their clinical significanceAdjuvant cellular immunotherapy in patients with resected primary non-small cell lung cancerDNA Methylation-Derived Neutrophil-to-Lymphocyte Ratio: An Epigenetic Tool to Explore Cancer Inflammation and Outcomes.Improved panels for clinical immune phenotyping: Utilization of the violet laser.Distinct Transcriptional and Anti-Mycobacterial Profiles of Peripheral Blood Monocytes Dependent on the Ratio of Monocytes: Lymphocytes.Identification of early myeloid progenitors as immunosuppressive cells.Relevance of Interferon Regulatory Factor-8 Expression in Myeloid-Tumor Interactions.A clinical and biological perspective of human myeloid-derived suppressor cells in cancer.The role of myeloid cells in cancer therapies.Myeloid-derived suppressor activity is mediated by monocytic lineages maintained by continuous inhibition of extrinsic and intrinsic death pathways.The functional interplay between systemic cancer and the hematopoietic stem cell niche.Mechanisms overseeing myeloid-derived suppressor cell production in neoplastic disease.Development of a Modular Assay for Detailed Immunophenotyping of Peripheral Human Whole Blood Samples by Multicolor Flow Cytometry.Lead transiently promotes granulocyte-macrophage progenitor differentiation and subsequently suppresses common myeloid progenitor differentiation.Simultaneous measurement of human hematopoietic stem and progenitor cells in blood using multicolor flow cytometry.Circulating Tumor Cells: Who is the Killer?IFN-γ-STAT1-iNOS Induces Myeloid Progenitors to Acquire Immunosuppressive Activity.Neutrophil-to-lymphocyte ratio and overall survival in all sites of head and neck squamous cell carcinoma.Osteoblasts remotely supply lung tumors with cancer-promoting SiglecFhigh neutrophils.The Granulocyte Progenitor Stage Is a Key Target of IRF8-Mediated Regulation of Myeloid-Derived Suppressor Cell Production.Melanoma induced immunosuppression is mediated by hematopoietic dysregulation.The protumorigenic potential of FTY720 by promoting extramedullary hematopoiesis and MDSC accumulation.Cross-talk between T Cells and Hematopoietic Stem Cells during Adoptive Cellular Therapy for Malignant Glioma.
P2860
Q33816141-F5490DB4-D823-4513-BDFF-651E85379AB4Q34810257-AC3D7F9A-6669-4757-A3AC-6E4CC6315DA3Q35090032-DDC24D2F-C86F-45DB-9FC6-1DFEFABE0D26Q35168107-19239833-E05C-4B27-BFFB-AC45CBCF1857Q35178139-DB035364-7F0D-47B8-BC48-E8059FED3CF5Q36060352-30F99222-6837-4DA5-B5A4-EDA624A941B4Q36222815-1876B661-BA1E-4646-BDD2-7866A0C99514Q36368756-0735ACAB-FD4E-46AE-9BFA-8AC0FC2C06C4Q36540944-0031C952-F0C2-417F-A7C0-D24C4EBC4620Q36691045-B476AF8A-4242-47A7-B122-E4C905EA8305Q37062216-DF621F2E-D70B-4ED3-8428-0DFC39E47ED7Q38847251-94CAAEE8-2BA3-4744-A723-39BC737DE3E9Q38875474-679DF890-91A7-456E-905F-5A24ADBC1AB3Q38929374-BE8FF577-3B58-437A-AF57-F1116932C8ABQ38946667-6EF253D1-8A85-4E84-9E35-2F4C27F3B570Q39146128-755A6090-3D60-4F91-8637-F7E27A68D487Q40952760-79CBEE4C-A88F-43FB-A2A5-723D7BDB2FA5Q41925376-58739FB8-71FD-4650-97B5-A4564F4FFAD4Q42003213-2C6887D2-B5E0-4924-9372-A7FE13988C1BQ42199364-C48DCD0B-D64F-4C5C-BF62-7035D554FDB4Q42364557-70F4AC85-AD46-487D-9FF8-E3B88B9B50E4Q42707140-9BF0142E-13C8-4682-B73F-741D14C8631EQ48207560-F7528A23-0800-4F62-AC37-38C9A8470AABQ48347565-6968B164-6559-4BDC-BD93-05F6498DCDEEQ50422852-B2912BDB-B262-4DC0-874F-527A3EC678DFQ52904194-EB0169C4-0801-4E4E-B181-BFE0866B9824Q55457224-8A7FAEA1-A92A-4721-AF9C-E23D989BE092
P2860
Circulating hematopoietic stem and progenitor cells are myeloid-biased in cancer patients.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 03 March 2014
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Circulating hematopoietic stem ...... oid-biased in cancer patients.
@en
Circulating hematopoietic stem ...... oid-biased in cancer patients.
@nl
type
label
Circulating hematopoietic stem ...... oid-biased in cancer patients.
@en
Circulating hematopoietic stem ...... oid-biased in cancer patients.
@nl
prefLabel
Circulating hematopoietic stem ...... oid-biased in cancer patients.
@en
Circulating hematopoietic stem ...... oid-biased in cancer patients.
@nl
P2093
P2860
P356
P1476
Circulating hematopoietic stem ...... oid-biased in cancer patients.
@en
P2093
Hai-Tian Chen
Hong-Wei Sun
Jing Liang
Limin Zheng
Wen-Chao Wu
Xing-Juan Yu
Zilian Wang
P2860
P304
P356
10.1073/PNAS.1320753111
P407
P577
2014-03-03T00:00:00Z